Virodhamine是一种内源性大麻素，是CB1受体的拮抗剂和CB2受体的激动剂。Virodhamine可用于阿尔茨海默病等神经系统疾病的研究。

Virodhamine, an endocannabinoid, is an antagonist of CB1 receptor and an agonist of CB2 receptor. Virodhamine can be used for the research of neurological disorders such as Alzheimer's diseases.

virodhamine (50nM, 72h) treatment augmented features associated with megakaryocytic development: cells increased adherence and membrane expansion. virodhamine (10, 20, 40 μM, 72h) treatment increases the expression of CD61[1].

Virodhamine (1, 5, 10 mg/kg; i.p. once) repairs the nicotine (0.8 mg/kg) and immobilization stress induced anxiety in Male ICR mice[2].

287937-12-6

C22H37NO2

347.53

O-arachidonoyl ethanolamine

DMSO:90mg/mL (259mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years